相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interfering with the Dimerization of the ErbB Receptors by Transmembrane Domain-Derived Peptides Inhibits Tumorigenic Growth in Vitro and in Vivo
Erez M. Bublil et al.
BIOCHEMISTRY (2016)
The Multifaceted Role of Perivascular Macrophages in Tumors
Claire E. Lewis et al.
CANCER CELL (2016)
Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment
Paola Moreno et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization
Marco Genua et al.
INFLAMMATORY BOWEL DISEASES (2016)
Glioma-targeted therapy using Cilengitide nanoparticles combined with UTMD enhanced delivery
Ying-Zheng Zhao et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides
Tingting Lin et al.
ACTA PHARMACEUTICA SINICA B (2016)
Peptide therapeutics: current status and future directions
Keld Fosgerau et al.
DRUG DISCOVERY TODAY (2015)
Advances in phage display technology for drug discovery
Kobra Omidfar et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
What is the future of PEGylated therapies?
Magdalena Swierczewska et al.
EXPERT OPINION ON EMERGING DRUGS (2015)
Chemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic Agents
Julio Valdivia-Silva et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides
Noriyasu Kamei et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Attenuation of microglial activation in a mouse model of Alzheimer's disease via NFAT inhibition
Lalida Rojanathammanee et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Moving targets: Emerging roles for MMPs in cancer progression and metastasis
Gemma Shay et al.
MATRIX BIOLOGY (2015)
Tumour exosome integrins determine organotropic metastasis
Ayuko Hoshino et al.
NATURE (2015)
Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Wenchao Zhou et al.
NATURE CELL BIOLOGY (2015)
Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study
L. Burt Nabors et al.
NEURO-ONCOLOGY (2015)
Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor
Yujie Zhao et al.
ONCOLOGIST (2015)
pHLIP-mediated targeting of truncated tissue factor to tumor vessels causes vascular occlusion and impairs tumor growth
Suping Li et al.
ONCOTARGET (2015)
Modulation of CD44 activity by A6-peptide
Malcolm Finlayson
FRONTIERS IN IMMUNOLOGY (2015)
TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis
Panagiotis Papageorgis
JOURNAL OF ONCOLOGY (2015)
Strategic Approaches to Optimizing Peptide ADME Properties
Li Di
AAPS JOURNAL (2015)
RVG-Peptide-Linked Trimethylated Chitosan for Delivery of siRNA to the Brain
Yikun Gao et al.
BIOMACROMOLECULES (2014)
Peptide-based cancer therapy: Opportunity and challenge
Dongdong Wu et al.
CANCER LETTERS (2014)
The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma
Amnon Peled et al.
CLINICAL CANCER RESEARCH (2014)
The extracellular matrix modulates the hallmarks of cancer
Michael W. Pickup et al.
EMBO REPORTS (2014)
Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity
Xiang Yi et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Roger Stupp et al.
LANCET ONCOLOGY (2014)
Interaction between Cell-Penetrating Peptides and Acid-Sensitive Anionic Oligopeptides as a Model for the Design of Targeted Drug Carriers
Chunmeng Sun et al.
MOLECULAR PHARMACEUTICS (2014)
Cell penetrating peptides: Efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules
Samad Mussa Farkhani et al.
PEPTIDES (2014)
Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier
Ja-Young Kim et al.
BIOMATERIALS (2013)
The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells
Guangzhi Gu et al.
BIOMATERIALS (2013)
Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel
Quanyin Hu et al.
BIOMATERIALS (2013)
Integrin control of the transforming growth factor-β pathway in glioblastoma
Patrick Roth et al.
BRAIN (2013)
NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice
Li Zhang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth
Lin Cheng et al.
CELL (2013)
Improving Binding Affinity and Stability of Peptide Ligands by Substituting Glycines with D-Amino Acids
Shiyu Chen et al.
CHEMBIOCHEM (2013)
Polycyclic Peptide Therapeutics
Vanessa Baeriswyl et al.
CHEMMEDCHEM (2013)
Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Correlations of Therapeutic Peptides
Lei Diao et al.
CLINICAL PHARMACOKINETICS (2013)
Cell-free translation of peptides and proteins: from high throughput screening to clinical production
Christopher J. Murray et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2013)
Future directions for peptide therapeutics development
Allan A. Kaspar et al.
DRUG DISCOVERY TODAY (2013)
Phage selection of bicyclic peptides
Inmaculada Rentero Rebollo et al.
METHODS (2013)
Family of pH (low) insertion peptides for tumor targeting
Dhammika Weerakkody et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis
Bhavani Krishnan et al.
PROSTATE (2013)
Identification of a novel peptide that blocks basic fibroblast growth factor-mediated cell proliferation
Xiaoping Wu et al.
ONCOTARGET (2013)
Cell surface binding and uptake of arginine- and lysine-rich penetratin peptides in absence and presence of proteoglycans
Helene L. Amand et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2012)
Tuning the Activity of Mitochondria-Penetrating Peptides for Delivery or Disruption
Kristin L. Horton et al.
CHEMBIOCHEM (2012)
Cell-penetrating peptides: classes, origin, and current landscape
Francesca Milletti
DRUG DISCOVERY TODAY (2012)
Cell-penetrating peptides for the delivery of nucleic acids
Taavi Lehto et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Flexible or fixed: a comparative review of linear and cyclic cancer-targeting peptides
Aron Roxin et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Cell permeable NFAT inhibitory peptide Sim-2-VIVIT inhibits T-cell activation and alleviates allergic airway inflammation and hyper-responsiveness
Je-Min Choi et al.
IMMUNOLOGY LETTERS (2012)
The extracellular matrix: A dynamic niche in cancer progression
Pengfei Lu et al.
JOURNAL OF CELL BIOLOGY (2012)
Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake
Astrid Subrizi et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Tumor-Associated Microglia/Macrophages Enhance the Invasion of Glioma Stem-like Cells via TGF-β1 Signaling Pathway
Xian-zong Ye et al.
JOURNAL OF IMMUNOLOGY (2012)
Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model
Shu-Chi Wang et al.
LABORATORY INVESTIGATION (2012)
Selection and characterization of tenascin C targeting peptide
Mee Young Kim et al.
MOLECULES AND CELLS (2012)
Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype
Yuji Piao et al.
NEURO-ONCOLOGY (2012)
Cilengitide Treatment for Malignant Glioma: Current Status and Future Direction
Kazuhiko Kurozumi et al.
NEUROLOGIA MEDICO-CHIRURGICA (2012)
A Cell Permeable Peptide Inhibitor of NFAT Inhibits Macrophage Cytokine Expression and Ameliorates Experimental Colitis
Houda Z. Elloumi et al.
PLOS ONE (2012)
TumorHoPe: A Database of Tumor Homing Peptides
Pallavi Kapoor et al.
PLOS ONE (2012)
Cell-penetrating peptides: breaking through to the other side
Erez Koren et al.
TRENDS IN MOLECULAR MEDICINE (2012)
CPPsite: a curated database of cell penetrating peptides
Ankur Gautam et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2012)
Applications of Cell-Penetrating Peptides for Tumor Targeting and Future Cancer Therapies
Jakob Regberg et al.
PHARMACEUTICALS (2012)
Two dileucine motifs mediate late endosomal/lysosomal targeting of transmembrane protein 192 (TMEM192) and a C-terminal cysteine residue is responsible for disulfide bond formation in TMEM192 homodimers
Joerg Behnke et al.
BIOCHEMICAL JOURNAL (2011)
PepCrawler: a fast RRT-based algorithm for high-resolution refinement and binding affinity estimation of peptide inhibitors
Elad Donsky et al.
BIOINFORMATICS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Peptides and Proteins as a Continuing Exciting Source of Inspiration for Peptidomimetics
Rob M. J. Liskamp et al.
CHEMBIOCHEM (2011)
The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
Maria Vincenza Carriero et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer
Jo Vandercappellen et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Stability of peptides and therapeutic success in cancer
Marlene Pernot et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Inhibition of Matrix Metalloproteinase 14 (MMP-14)-mediated Cancer Cell Migration
Kevin Zarrabi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Inverted micelle formation of cell-penetrating peptide studied by coarse-grained simulation: Importance of attractive force between cell-penetrating peptides and lipid head group
Shuhei Kawamoto et al.
JOURNAL OF CHEMICAL PHYSICS (2011)
Can We Trust Docking Results? Evaluation of Seven Commonly Used Programs on PDBbind Database
Dariusz Plewczynski et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)
The secreted factors responsible for pre-metastatic niche formation: Old sayings and new thoughts
Hector Peinado et al.
SEMINARS IN CANCER BIOLOGY (2011)
Cross Talk among TGF-β Signaling Pathways, Integrins, and the Extracellular Matrix
John S. Munger et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Homeostatic chemokine receptors and organ-specific metastasis
Albert Zlotnik et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Cell-penetrating peptide exploited syndecans
Tarnas Letoha et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2010)
A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery
Yang Liu et al.
BIOMATERIALS (2010)
Synthetic therapeutic peptides: science and market
Patrick Vlieghe et al.
DRUG DISCOVERY TODAY (2010)
Design and development of peptides and peptide mimetics as antagonists for therapeutic intervention
Jody M. Mason
FUTURE MEDICINAL CHEMISTRY (2010)
Transport across the Blood-Brain Barrier of Pluronic Leptin
Tulin O. Price et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Multiple N-Methylation of MT-II Backbone Amide Bonds Leads to Melanocortin Receptor Subtype hMC1R Selectivity: Pharmacological and Conformational Studies
Lucas Doedens et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
The soluble form of urokinase receptor promotes angiogenesis through its Ser88-Arg-Ser-Arg-Tyr92 chemotactic sequence
K. Bifulco et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases
Reinhard Gabathuler
NEUROBIOLOGY OF DISEASE (2010)
Peptide-based interference of the transmembrane domain of neuropilin-1 inhibits glioma growth in vivo
C. Nasarre et al.
ONCOGENE (2010)
Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery
Mei Lin Tan et al.
PEPTIDES (2010)
Can self-inhibitory peptides be derived from the interfaces of globular protein-protein interactions?
Nir London et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2010)
The Structural Basis of Peptide-Protein Binding Strategies
Nir London et al.
STRUCTURE (2010)
Strategies to prolong the plasma residence time of peptide drugs
Lisa Pollaro et al.
MEDCHEMCOMM (2010)
The renin-angiotensin system and cancer: old dog, new tricks
Amee J. George et al.
NATURE REVIEWS CANCER (2010)
A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growth
Juho Suojanen et al.
CANCER BIOLOGY & THERAPY (2009)
Importing Mitochondrial Proteins: Machineries and Mechanisms
Agnieszka Chacinska et al.
CELL (2009)
Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides
Todd A. Aguilera et al.
INTEGRATIVE BIOLOGY (2009)
Matrix Metalloproteinases As Novel Biomarkers and Potential Therapeutic Targets in Human Cancer
Roopali Roy et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models
Marianne Schrader de Oliveira et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor
David R. Soto-Pantoja et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors
Andrew R. Reynolds et al.
NATURE MEDICINE (2009)
CNS Delivery Via Adsorptive Transcytosis
Francoise Herve et al.
AAPS JOURNAL (2008)
Proteases for processing proneuropeptides into peptide neurotransmitters and hormones
Vivian Hook et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Distinct Uptake Routes of Cell-Penetrating Peptide Conjugates
Per Lundin et al.
BIOCONJUGATE CHEMISTRY (2008)
Design of a tumor-homing cell-penetrating peptide
Helena Myrberg et al.
BIOCONJUGATE CHEMISTRY (2008)
Translating an Antagonist of Chemokine Receptor CXCR4: From Bench to Bedside
Donald Wong et al.
CLINICAL CANCER RESEARCH (2008)
Peptides as protein binding site mimetics
Jutta Eichler
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Microglia-derived TGF-β as an important regulator of glioblastoma invasion -: an inhibition of TGF-β-dependent effects by shRNA against human TGF-β type II receptor
A. Wesolowska et al.
ONCOGENE (2008)
Multiple N-methylation by a designed approach enhances receptor selectivity
Jayanta Chatterjee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Delivery of short interfering RNA using endosomolytic cell-penetrating peptides
Pontus Lundberg et al.
FASEB JOURNAL (2007)
Transvascular delivery of small interfering RNA to the central nervous system
Priti Kumar et al.
NATURE (2007)
Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo
Oleg A. Andreev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors
Vijay A. Sethuraman et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Endoplasmic reticulum and golgi localization sequences for mammalian target of rapamycin
Xiangyu Liu et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone
Joerg B. Engel et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
Effect of the angiogenesis inhibitor cilengitide (EMD 121974) on glioblastoma growth in nude mice
Shinya Yamada et al.
NEUROSURGERY (2006)
Therapeutic peptides: technological advances driving peptides into development
Aaron K. Sato et al.
CURRENT OPINION IN BIOTECHNOLOGY (2006)
Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1
Anna Starzec et al.
LIFE SCIENCES (2006)
Is the oral route possible for peptide and protein drug delivery
Mariko Morishita et al.
DRUG DISCOVERY TODAY (2006)
A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo
Parisa Khalili et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The neuropilins and their role in tumorigenesis and tumor progression
N Guttmann-Raviv et al.
CANCER LETTERS (2006)
Current strategies for the development of peptide-based anti-cancer therapeutics
C Borghouts et al.
JOURNAL OF PEPTIDE SCIENCE (2005)
Å6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer:: A phase I trial
A Berkenblit et al.
GYNECOLOGIC ONCOLOGY (2005)
The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis
RA Cardone et al.
NATURE REVIEWS CANCER (2005)
Re-evaluating the role of strongly charged sequences in amphipathic cell-penetrating peptides - A fluorescence study using Pep-1
ST Henriques et al.
FEBS LETTERS (2005)
Potential oncogenic action of tenascin-C in tumorigenesis
G Orend
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Anti-Flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis
DG Bae et al.
CLINICAL CANCER RESEARCH (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The use of cell-penetrating peptides as a tool for gene regulation
P Järver et al.
DRUG DISCOVERY TODAY (2004)
Tyrosine kinase receptors as attractive targets of cancer therapy
A Bennasroune et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
Transduction peptides: from technology to physiology
A Joliot et al.
NATURE CELL BIOLOGY (2004)
In vitro gene delivery by a novel human calcitonin (hCT)-derived carrier peptide
U Krauss et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Suppression of tumor growth and metastasis by a vegfr-1 antagonizing peptide identified from a phage display library
P An et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
T Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Phage display-derived peptides as a therapeutic alternatives to antibodies
RC Ladner et al.
DRUG DISCOVERY TODAY (2004)
The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components
D Seebach et al.
CHEMISTRY & BIODIVERSITY (2004)
Thermally reversible hydrogels via intramolecular folding and consequent self-assembly of a de Novo designed peptide
DJ Pochan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Studies on the internalization mechanism of cationic cell-penetrating peptides
G Drin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells
F Simeoni et al.
NUCLEIC ACIDS RESEARCH (2003)
Inhibition of integrin α5β1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice
O Stoeltzing et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Integrin αvβ3 as a therapeutic target for blocking tumor-induced angiogenesis
CC Kumar
CURRENT DRUG TARGETS (2003)
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma
JA Hoffman et al.
CANCER CELL (2003)
A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor
HT Lei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The SPOT synthesis technique - Synthetic peptide arrays on membrane supports - principles and applications
R Frank
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Tryptophan fluorescence study of the interaction of penetratin peptides with model membranes
B Christiaens et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Converting a peptide into a drug: Strategies to improve stability and bioavailability
C Adessi et al.
CURRENT MEDICINAL CHEMISTRY (2002)
αν-integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin
T Taga et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
NFAT signaling: Choreographing the social lives of cells
GR Crabtree et al.
CELL (2002)
Arginine-rich peptides - An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery
S Futaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters
PA Wender et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53
C García-Echeverría et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo
YJ Guo et al.
FASEB JOURNAL (2000)
Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin
S Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
